Ketamine-Assisted Psychotherapy (KAP)
Ketamine is a legal, safe, and effective medicine used to treat a variety of mental health conditions. Guided by an attuned, skilled therapist, Ketamine can facilitate helpful shifts in perspective and allow access to parts of the psyche typically unavailable in ordinary states of consciousness. Difficult past memories can be faced with greater self-compassion. The Default Mode Network of the brain, where repetitive, negative beliefs reside, is temporarily quieted down so that wisdom from Core Self can more easily be discerned. Ketamine increases brain neuroplasticity in the days and weeks following treatment, and can be utilized to initiate and sustain healthier habits.
I offer KAP in partnership with Journey Clinical. I take on the psychotherapeutic component of the experience, while Journey Clinical’s psychiatric team supports you on all medical aspects. Once you’ve completed the medical screening and are cleared for KAP treatment, we will explore in session your intentions for your Ketamine journey. We’ll schedule your dosing session, which is typically 2.5-3 hours long, as well as your integration sessions in which we process your experience and discuss how to bring your new insights into daily life and take advantage of the increased neuroplasticity in your brain. More than one such cycle may be prescribed, depending on your treatment plan.
Though I recommend in-person sessions for KAP treatment, under the right conditions we may be able to work together virtually. I would be happy to consult with you by phone to help you determine if Ketamine-Assisted Therapy could be right for you. The articles below may help you learn more about this exciting treatment.
Toward Synergies of Ketamine and Psychotherapy
Frontiers in Psychology
An Integrative Approach to KAP May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment-Resistant Depression
Frontiers in Psychiatry
Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy
Journal of Psychoactive Drugs